Back

Impact of implantable cardioverter defibrillator therapy in patients with hypertrophic cardiomyopathy

21 May 2022 (08:30 - 18:50)
Organised by:
Congress Presentation Part of: Heart Failure ePosters - focus on Arrhythmias and device Implantable Cardioverter-Defibrillator (ICD) HFA Premium Access Heart Failure 2022

About the speaker

Photo
Mr Charles Slater

Hospital Pro Cardiaco, Rio de Janeiro (Brazil)

18 More presentations in this session

Presentation thumbnail
New-onset atrial fibrillation in ST-segment elevation myocardial infarction: does gender matter?
Doctor C. Marques Pires (Braga, PT)
Abstract Slides
Presentation thumbnail
The Netherlands Heart Tissue Bank
Mr M. Henkens (Maastricht, NL)
Abstract Slides
Presentation thumbnail
Comparative assessment of the features of atrial fibrillation occurrence in heart failure patients with preserved and mildly reduced ejection fraction
Professor S. Grigoryan (Yerevan, AM)
Abstract Slides
Presentation thumbnail
Gender, ethnic difference in arrhythmic risks and prognosis in patients with non-ischaemic cardiomyopathy
Doctor I. Chung (Singapore, SG)
Abstract Slides
Presentation thumbnail
Patients with non-ischemic dilated cardiomyopathy and AF exhibit worse global longitudinal strain and reduced work index and constructive work of the myocardium compared to those without AF
Doctor J. Borovac (Split, HR)
Abstract Slides

Access the full session

Session thumbnail
Heart Failure ePosters - focus on Arrhythmias and device

The Event

Event poster

Heart Failure 2022

21 May 2022 08:30 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources